Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Primary Cardiac Leiomyosarcoma in a Young Patient: A Therapeutic Challenge.

Created on 06 Aug 2026

Authors

Harold R Calzadilla-Gutierrez, Narel Blanco-Adrian, Juan M Vaca-Villarroel, Victoria R Ticona-Cocarico, Camila Cazuriaga, Camila A Flores-Choque

Published in

JACC. Case reports. Pages 109667. Aug 06, 2026. Epub Aug 06, 2026.

Abstract

Primary cardiac leiomyosarcoma is an extremely rare and aggressive sarcoma. Its diagnosis is challenging, and its treatment is not yet standardized, resulting in a poor prognosis.
A 29-year-old man presented with a 1-month history of respiratory symptoms, initially treated with antiflu medication and antibiotics, showing no clinical improvement. During cardiology consultation, a cardiac mass was identified on echocardiography and subsequently characterized by cardiac magnetic resonance and positron emission tomography. Histopathological and immunohistochemical studies confirmed the diagnosis. The patient remains alive at 20 months while receiving systemic treatment.
The diagnosis of primary cardiac leiomyosarcoma is challenging due to its rarity and aggressive behavior; it requires multimodal imaging and immunohistochemical confirmation. Its treatment remains nonstandardized, with limited evidence supporting the benefit of combining surgery, chemotherapy, and/or radiotherapy. This case highlights the importance of timely diagnosis and documents longer survival than typically reported.

PMID:
42560293
Bibliographic data and abstract were imported from PubMed on 06 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement